Mertens Steve 4

What Happened

• Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies Corp (NMTC), had 7,376 shares withheld to satisfy a tax liability (reported as a disposition). The shares were valued at $0.68 each, totaling approximately $5,016.
• This was a tax-withholding transaction (Code F) — a routine disposition rather than an open-market sale or new purchase.

Key Details

• Transaction date: 2026-02-18; Filing date: 2026-02-20 (Form 4 accession 0001772652-26-000004).
• Transaction type and code: Tax withholding/payment of tax liability (Code F); reported as "Disposed."
• Shares involved: 7,376 shares at $0.68 per share; total value ≈ $5,016.
• Shares owned after the transaction: not disclosed in the provided filing.
• Timeliness: Filing was submitted two days after the reported transaction date (not flagged as late).
• Note: Code F transactions commonly follow option exercises or vesting and reflect shares withheld to cover taxes.

Context

• This is a routine tax-withholding action and should not be interpreted as an open-market sale or a directional trade signal. For derivative exercises, withheld shares are often used to satisfy tax obligations rather than generate cash proceeds.